O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+9.02%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$5.37M
AUM Growth
+$5.37M
(-2.2%)
Cap. Flow
-$267K
Cap. Flow
% of AUM
-4.97%
Top 10 Holdings %
Top 10 Hldgs %
30.7%
Holding
153
New
13
Increased
31
Reduced
32
Closed
21
Top Buys
| 1 |
THRD
Third Harmonic Bio
THRD
|
$110K |
| 2 |
Sarepta Therapeutics
SRPT
|
$99.3K |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$50.1K |
| 4 |
Thermo Fisher Scientific
TMO
|
$45K |
| 5 |
BLU
BELLUS Health Inc.
BLU
|
$33.6K |
Top Sells
Sector Composition
| 1 | Healthcare | 98.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
RxSight
RXST
$363M
| $14.4K | 0.27% |
1,202,833
-180,667
| -13% | -$2.17K |
|
|
JBIO
77
Jade Biosciences, Inc. Common Stock
JBIO
$249M
| $13.2K | 0.24% |
795,000
+316,421
| +66% | +$5.25K |
|
78
Passage Bio
PASG
$22.5M
| $11.2K | 0.21% |
8,931,999
| – | – |
|
79
Mirum Pharmaceuticals
MIRM
$3.72B
| $11K | 0.2% |
521,891
+242,391
| +87% | +$5.09K |
|
|
IMA
80
ImageneBio, Inc. Common Stock
IMA
$152M
| $10.4K | 0.19% |
2,933,941
| – | – |
|
|
CINC
81
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $10.3K | 0.19% |
+314,202
| New | +$10.3K |
|
82
Enliven Therapeutics
ELVN
$1.24B
| $10K | 0.19% |
4,386,568
| – | – |
|
|
FUSN
83
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $9.71K | 0.18% |
3,224,770
| – | – |
|
84
Disc Medicine
IRON
$2.15B
| $9.56K | 0.18% |
5,826,223
-1
| -0% | – |
|
|
MREO
85
Mereo BioPharma
MREO
$275M
| $9.13K | 0.17% |
10,605,522
+8,004,054
| +308% | +$6.89K |
|
86
X4 Pharmaceuticals
XFOR
$70.7M
| $8.6K | 0.16% |
5,026,817
+3,652,968
| +266% | +$6.25K |
|
87
Cullinan Oncology
CGEM
$455M
| $8.17K | 0.15% |
637,287
-33,500
| -5% | -$429 |
|
88
Arcus Biosciences
RCUS
$1.23B
| $7.93K | 0.15% |
+303,000
| New | +$7.93K |
|
89
Ventyx Biosciences
VTYX
$186M
| $7.86K | 0.15% |
225,000
-1,064,280
| -83% | -$37.2K |
|
90
Galecto
GLTO
$3.93M
| $7.73K | 0.14% |
4,090,937
| – | – |
|
91
EyePoint Pharmaceuticals
EYPT
$824M
| $7.68K | 0.14% |
970,860
+756,760
| +353% | +$5.99K |
|
92
NextCure
NXTC
$13.1M
| $7.46K | 0.14% |
2,711,013
| – | – |
|
93
Pulmonx
LUNG
$66M
| $7.25K | 0.13% |
435,000
| – | – |
|
|
JNCE
94
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $6.85K | 0.13% |
2,928,900
| – | – |
|
95
Oric Pharmaceuticals
ORIC
$1.03B
| $6.68K | 0.12% |
2,087,568
| – | – |
|
|
CMMB
96
Chemomab Therapeutics
CMMB
$15.8M
| $6.42K | 0.12% |
2,578,174
| – | – |
|
97
SPDR S&P Biotech ETF
XBI
$5.27B
| $6.06K | 0.11% |
76,400
-35,400
| -32% | -$2.81K |
|
98
Synlogic
SYBX
$17.2M
| $5.73K | 0.11% |
6,029,995
| – | – |
|
99
Corvus Pharmaceuticals
CRVS
$429M
| $5.68K | 0.11% |
6,943,654
| – | – |
|
|
CYBN
100
Cybin
CYBN
$139M
| $5.08K | 0.09% |
10,453,600
-70,700
| -0.7% | -$34 |
|